CSI Market
Sign In | Register

Blueprint Medicines (BPMC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BPMC Annual Balance Sheets →
This page allows investors to track Blueprint Medicines's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent122.25
Available-for-sale Securities, Debt Securities, Current MA453.99
Cash & Short-term Investments575.00
Accounts receivable78.08
Inventories12.95
Other Current Assets1.72
Prepaid Expense And Other Assets Current33.08
Total Current Assets702.07
Equipment/Property/Plant Net36.05
Long-term investments323.55
Other Assets, Noncurrent133.94
Unbilled Receivables Including Reimbursable Costs Current1.72
Operating Lease Right Of Use Asset61.61
Restricted Cash Noncurrent11.85
Total Assets1,195.60
Liabilities
Accounts Payable, Current AC0.80
Accrued Liabilities, Current AC122.06
Secured Debt, Current LO43.80
Other Liabilities, Current83.93
Total Current Liabilities250.58
Long-term debt343.95
Capital Lease and Other67.92
Total Long-term Debt411.87
Other liabilities, Noncurrent191.02
Contract With Customer Liability Current2.28
Operating Lease Liability Noncurrent65.22
Contract With Customer Liability Noncurrent8.04
Total Liabilities853.47
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock2,751.84
Retained Earnings / Accumulated Deficit-2,406.54
Other Equity-3.24
Common Stockholder's Equity342.13
Total Stockholder's Equity342.13
Liabilities & Stockholder's Equity1,195.60
4 historic quarters locked

Sign in to unlock the full Blueprint Medicines balance sheet history.

Sign In Create Free Account

About Blueprint Medicines Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-006108

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.